EAM Investors, LLC - IMMUNOMEDICS INC ownership

IMMUNOMEDICS INC's ticker is IMMU and the CUSIP is 452907108. A total of 83 filers reported holding IMMUNOMEDICS INC in Q3 2013. The put-call ratio across all filers is 0.57 and the average weighting 0.0%.

Quarter-by-quarter ownership
EAM Investors, LLC ownership history of IMMUNOMEDICS INC
ValueSharesWeighting
Q2 2020$1,897,000
-7.1%
53,540
-45.4%
0.42%
+37.8%
Q3 2018$2,042,000
-41.5%
98,026
-33.5%
0.30%
-44.7%
Q2 2018$3,489,000
+374.7%
147,400
+193.2%
0.55%
+350.8%
Q1 2018$735,000
-25.9%
50,280
-18.1%
0.12%
-31.5%
Q4 2017$992,000
-81.7%
61,412
-84.2%
0.18%
-75.3%
Q3 2017$5,419,000
+21.0%
387,616
-23.6%
0.72%
-2.7%
Q2 2017$4,478,000
+404.8%
507,114
+270.1%
0.74%
+428.6%
Q1 2017$887,000
-24.0%
137,028
-27.3%
0.14%
-39.9%
Q3 2013$1,167,000
+13.5%
188,594
-0.2%
0.23%
+4.5%
Q2 2013$1,028,000188,9190.22%
Other shareholders
IMMUNOMEDICS INC shareholders Q3 2013
NameSharesValueWeighting ↓
Avoro Capital Advisors LLC 17,714,461$368,992,00016.94%
ACUTA CAPITAL PARTNERS, LLC 2,055,500$42,816,00015.27%
Foresite Capital Management III, LLC 2,691,729$56,069,00012.37%
Foresite Capital Management IV, LLC 1,231,543$25,653,0008.41%
NEXTHERA CAPITAL LP 1,398,577$29,132,0005.58%
Palo Alto Investors LP 5,013,764$104,437,0004.22%
Ghost Tree Capital, LLC 883,823$18,410,0003.91%
First Light Asset Management, LLC 1,151,622$23,988,0003.87%
DLD Asset Management, LP 3,403,000$70,918,0003.51%
RA Capital Management 3,119,778$64,985,0003.47%
View complete list of IMMUNOMEDICS INC shareholders